Russia's COVID-19 vaccine set for mass rollout in October; check details

Henrietta Brewer
August 3, 2020

Earlier this month, the UN Human Rights Council stressed the importance of "equitable and unhindered access" to diagnostics, treatments and vaccines, and said any vaccine developed against COVID-19 should be considered a "global public good".

As scientists and pharmaceutical companies work at breakneck speed to develop a vaccine for coronavirus, public health officials and senior USA lawmakers are sounding alarms about the Trump administration's lack of planning for its nationwide distribution. Since Covid-19 infections have dropped dramatically in Britain, making it hard to determine whether or not the vaccine works, Shattock said he and his colleagues are also looking to test their vaccine elsewhere.

Sanofi CEO Paul Hudson drew the ire of French officials in May when he suggested any COVID-19 vaccine would be offered first to the U.S. government because it had been investing in its development.

It further states, "the high-income countries could act as an inclusive worldwide buyers' group, thus accelerating the development of safe and effective vaccines and maximise access to them for all who need it across the world".


It comes under the Trump administration's Operation Warp Speed, meant to rush a COVID-19 vaccine to the market by the end of 2020.

As large trials get underway to test the vaccines needed to stop the global coronavirus pandemic, one group has realized they are being left out and is not happy: People living with HIV.

The latest investment holds the "potential to bring hundreds of millions of safe and effective doses to the American people", Azar said in the statement.

Sanofi, based in France, and GSK of Britain said clinical trials of their vaccine should start in September, with a Phase 3 study under way by the end of the year.


The trials in Brazil and the UAE will be watched particularly closely, given China's history of vaccine and other health scandals. "It really depends on how strong the immune response needs to be to provide protection". "SARS-CoV-2 is the virus that causes COVID-19", stated the release.

At least 1.4 million of them have recovered. Neither NIAID, which is led by long-time AIDS researcher Anthony Fauci, nor the company responded to queries from ScienceInsider this week.

"Drs. Williams and Jones are very excited to begin the Phase 3 trial of Moderna's vaccine here in Wilmington this coming week", Dattilo said in an email Thursday. Another program being codeveloped by one of the large vaccine makers Pfizer, but only after teaming up with German mRNA firm BioNTech, is in Phase II.

Russian Federation has released no scientific data proving the vaccines' safety or efficacy. Some Democratic members of Congress are calling for their inclusion, according to the Washington Post.


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER